Steven J. Kafka Sells 23,064 Shares of Foundation Medicine Inc (FMI) Stock

Foundation Medicine Inc (NASDAQ:FMI) COO Steven J. Kafka sold 23,064 shares of the business’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $70.13, for a total value of $1,617,478.32. Following the completion of the transaction, the chief operating officer now directly owns 61,361 shares of the company’s stock, valued at $4,303,246.93. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Steven J. Kafka also recently made the following trade(s):

  • On Tuesday, January 2nd, Steven J. Kafka sold 157 shares of Foundation Medicine stock. The shares were sold at an average price of $64.00, for a total value of $10,048.00.

Shares of Foundation Medicine Inc (NASDAQ FMI) opened at $64.85 on Friday. Foundation Medicine Inc has a 12-month low of $22.40 and a 12-month high of $75.20. The company has a current ratio of 2.24, a quick ratio of 2.03 and a debt-to-equity ratio of 0.47.

FMI has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded Foundation Medicine from a “hold” rating to a “buy” rating and set a $59.00 price objective for the company in a research report on Monday, November 6th. BidaskClub upgraded Foundation Medicine from a “hold” rating to a “buy” rating in a research report on Thursday, January 25th. Finally, Goldman Sachs Group initiated coverage on Foundation Medicine in a research report on Monday, January 29th. They issued a “neutral” rating and a $73.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $52.25.

Several institutional investors have recently bought and sold shares of the company. UBS Asset Management Americas Inc. purchased a new stake in shares of Foundation Medicine in the fourth quarter valued at approximately $241,000. Bank of New York Mellon Corp increased its position in shares of Foundation Medicine by 1.6% in the fourth quarter. Bank of New York Mellon Corp now owns 66,658 shares of the company’s stock valued at $4,546,000 after buying an additional 1,081 shares in the last quarter. Advisory Research Inc. increased its position in shares of Foundation Medicine by 172.2% in the fourth quarter. Advisory Research Inc. now owns 76,581 shares of the company’s stock valued at $5,223,000 after buying an additional 48,450 shares in the last quarter. Wells Fargo & Company MN increased its position in shares of Foundation Medicine by 31.2% in the fourth quarter. Wells Fargo & Company MN now owns 22,327 shares of the company’s stock valued at $1,523,000 after buying an additional 5,310 shares in the last quarter. Finally, First Trust Advisors LP purchased a new stake in shares of Foundation Medicine in the fourth quarter valued at approximately $1,939,000. Institutional investors and hedge funds own 33.12% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Steven J. Kafka Sells 23,064 Shares of Foundation Medicine Inc (FMI) Stock” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2018/02/10/steven-j-kafka-sells-23064-shares-of-foundation-medicine-inc-fmi-stock.html.

About Foundation Medicine

Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.

Insider Buying and Selling by Quarter for Foundation Medicine (NASDAQ:FMI)

Receive News & Ratings for Foundation Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply